Zhangzhou Pientzehuang Pharmaceutical | 600436 - Net Income

Stock Price
157.25
Daily Change
-1.05 -0.66%
Monthly
-5.46%
Yearly
-23.15%
Q1 Forecast
152.93

Zz Pientze Pharmaceu reported CNY687.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Jiangsu Hengrui CNY 1.3B 1.27B Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Moderna USD -200M 625M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Sh Fosun Pharma CNY 821.33M 115.88M Sep/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Wuxi Apptec CNY 3.51B 1.39B Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025